# Harmony Biosciences Holdings, Inc. (HRMY) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Harmony Biosciences Holdings, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/HRMY/mda/fy2025/): filed 2026-02-24; accession 0001104659-26-018859 (https://www.sec.gov/Archives/edgar/data/1802665/000110465926018859/hrmy-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/HRMY/mda/fy2024/): filed 2025-02-25; accession 0001558370-25-001441 (https://www.sec.gov/Archives/edgar/data/1802665/000155837025001441/hrmy-20241231x10k.htm)
- [FY 2023 MD&A](/company/HRMY/mda/fy2023/): filed 2024-02-22; accession 0001558370-24-001466 (https://www.sec.gov/Archives/edgar/data/1802665/000155837024001466/hrmy-20231231x10k.htm)
- [FY 2022 MD&A](/company/HRMY/mda/fy2022/): filed 2023-02-21; accession 0001558370-23-001574 (https://www.sec.gov/Archives/edgar/data/1802665/000155837023001574/hrmy-20221231x10k.htm)
- [FY 2021 MD&A](/company/HRMY/mda/fy2021/): filed 2022-02-28; accession 0001558370-22-002257 (https://www.sec.gov/Archives/edgar/data/1802665/000155837022002257/hrmy-20211231x10k.htm)

Back to /company/HRMY/